Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Authors:

Abstract
No abstract available
Funding Information
  • Merck KGaA

This publication has 29 references indexed in Scilit: